The store will not work correctly when cookies are disabled.
4-(2-(4-fluorobenzyloxy)ethoxy)-7H-furo[3,2-g]chromen-7-one
ID: ALA3953745
PubChem CID: 11638587
Max Phase: Preclinical
Molecular Formula: C20H16O5
Molecular Weight: 336.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1ccc2c(OCCOCc3ccccc3)c3ccoc3cc2o1
Standard InChI: InChI=1S/C20H16O5/c21-19-7-6-15-18(25-19)12-17-16(8-9-23-17)20(15)24-11-10-22-13-14-4-2-1-3-5-14/h1-9,12H,10-11,13H2
Standard InChI Key: PRFBIGZCKZSWSQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
17.7371 -1.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7382 -1.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4464 -2.3256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1538 -1.9147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4397 -0.6908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1464 -1.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2015 -4.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1997 -3.1529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9084 -3.5582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9072 -4.3788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6134 -4.7879 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3253 -4.3808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3264 -3.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6157 -3.1466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4935 -4.3813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4902 -3.5648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7126 -3.3156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2353 -3.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7179 -4.6367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0318 -4.7914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1971 -2.3357 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9035 -1.9248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6125 -2.3311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3189 -1.9203 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0279 -2.3266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 2 0
15 7 1 0
7 10 2 0
9 8 2 0
8 16 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 15 1 0
12 20 2 0
8 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 2 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.34 | Molecular Weight (Monoisotopic): 336.0998 | AlogP: 4.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 61.81 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.39 | Np Likeness Score: 0.25 |
References
1. (2006) 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel, |